Intervention not reported
Xpert MTB/RIF, people living with HIV · people living with HIV and non‐hospitalized people in high‐risk groups
1 finding from 1 review
Intervention not reported
Xpert Ultra, people living with HIV · people living with HIV and non‐hospitalized people in high‐risk groups
1 finding from 1 review
Intervention not reported
Xpert MTB/RIF, non‐hospitalized people in high‐risk groups · people living with HIV and non‐hospitalized people in high‐risk groups
1 finding from 1 review
Intervention not reported
Index test · people in high‐risk groups
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Xpert MTB/RIF · people in high‐risk groups
1 finding from 1 review
Mortality at 8 weeks · adults living with HIV
Effect of LF‐LAM probably leads to lower mortality at 8 weeks compared with no LF‐LAM on mortality and tuberculosis treatment initiation (moderate certainty).
1 finding from 1 review
People started on tuberculosis treatment · adults living with HIV
Effect of LF‐LAM showed no clear difference in people started on tuberculosis treatment compared with no LF‐LAM on mortality and tuberculosis treatment initiation (moderate certainty).
2 findings from 1 review
Mortality at 6 months · adults living with HIV
Effect of LF‐LAM showed no clear difference in mortality at 6 months compared with no LF‐LAM on mortality and tuberculosis treatment initiation (low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality · ≥ 15‐year‐old people with late second stage human African gambiense trypanosomiasis (trypanosomes in blood or nymph node fluid and WBC >…
The intervention showed no clear difference in all‐cause mortality (low certainty).
1 finding from 1 review
Intervention not reported
Relapsec · ≥ 15‐year‐old people with late second stage human African gambiense trypanosomiasis (trypanosomes in blood or nymph node fluid and WBC >…
The intervention probably leads to higher relapsec (moderate certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · ≥ 15‐year‐old people with late second stage human African gambiense trypanosomiasis (trypanosomes in blood or nymph node fluid and WBC >…
It is very uncertain whether the intervention changes serious adverse events (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events · ≥ 15‐year‐old people with late second stage human African gambiense trypanosomiasis (trypanosomes in blood or nymph node fluid and WBC >…
The intervention showed no clear difference in adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Diarrhoea lasting ≥ 48 hours · children and adults with acute infectious diarrhoea
The intervention showed no clear difference in diarrhoea lasting ≥ 48 hours (moderate certainty).
1 finding from 1 review
Intervention not reported
Mean duration of diarrhoea (hours) · children and adults with acute infectious diarrhoea
1 finding from 1 review
Intervention not reported
Treatment failure day‐28 PCR‐adjusted(PP population) · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention showed no clear difference in treatment failure day‐28 PCR‐adjusted(PP population) (low certainty).
1 finding from 1 review
Intervention not reported
Treatment failureday‐28 PCR‐adjusted(ITT population) · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention showed no clear difference in treatment failureday‐28 PCR‐adjusted(ITT population) (low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention showed no clear difference in serious adverse events (low certainty).
1 finding from 1 review
Intervention not reported
Drug‐related adverse events · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention probably leads to lower drug‐related adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Drug‐related vomiting · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention showed no clear difference in drug‐related vomiting (low certainty).
1 finding from 1 review
Intervention not reported
Acceptability · children aged 14 years or younger with uncomplicated P falciparum malaria
1 finding from 1 review